https://www.pharmaglobenewswire.com/epstein-barr-virus-ebv-market-poised-for-growth-driven-by-emerging-therapies-immunotherapy-advancements-and-unmet-medical-needs/Pharma Globenewswireen2026-10-09T10:47:20+01:00Epstein-Barr Virus (EBV) Market Poised for Growth Driven by Emerging Therapies, Immunotherapy Advancements, and Unmet Medical Needs https://www.pharmaglobenewswire.com/desmoid-tumors-market-to-witness-significant-growth-through-2034-amid-expanding-late-stage-pipeline/Pharma Globenewswireen2026-10-09T07:30:20+01:00Desmoid Tumors Market to Witness Significant Growth Through 2034 Amid Expanding Late-Stage Pipeline https://www.pharmaglobenewswire.com/intraocular-lens-market-set-to-witness-steady-growth-driven-by-advancing-eye-care-through-2032/Pharma Globenewswireen2026-10-08T08:43:13+01:00Intraocular Lens Market Set to Witness Steady Growth Driven by Advancing Eye Care Through 2032 https://www.pharmaglobenewswire.com/psoriasis-market-steady-growth-driven-by-advancements-in-biologic-and-oral-therapies-by-2034-2/Pharma Globenewswireen2026-10-08T04:24:05+01:00Psoriasis Market: Steady Growth Driven by Advancements in Biologic and Oral Therapies by 2034